Evaluation of treatment and long-term outcomes for recurrent hepatocellular carcinoma that was treated by surgery or radiofrequency ablation: a multicenter retrospective observational study (SURF-additional study)
Not Applicable
- Conditions
- A primary hepatocellular carcinoma case with tumor foci numbering less than 3, each measuring 3 cm or less, Child-Pugh score of 7 or less, ages between 20 and 79 year, and indications for either surgical resection or radiofrequency ablation for the treatment
- Registration Number
- JPRN-UMIN000028292
- Lead Sponsor
- Surgery vs. RFA (SURF) trial group
- Brief Summary
nder preparation
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 503
Inclusion Criteria
Not provided
Exclusion Criteria
1) Double cancer or history of other malignancy within 5 years after diagnosis 2) History of myocardial infarction or unstable angina within 6 months prior to registration 3) Patient with interstitial pneumonia, pneumofibrosis, or severe lung emphysema 4) Patient who cannot undergo enhanced CT scan due to some reason such as allergy for iodized contrast media or renal dysfunction 5) Patient with psychiatric disorder or symptom 6) Pregnant patient or patient with possibility to be pregnant
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence-free survival
- Secondary Outcome Measures
Name Time Method 1. Treatment selection after recurrence of hepatocellular carcinoma 2. Recurrence pattern 3. Tumor maker trend